Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Organic Letters|May 25, 2016
Isolation, Structure Elucidation, Biosynthesis, and Synthesis of Antalid, a Secondary Metabolite from Polyangium speciesThomas Tautz, Judith Hoffmann, Thomas Hoffmann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 5, 2018
Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPAJørn Eivind Tungen, Lisa Gerstmann, Anders Vik, et al.
The Journal of Organic Chemistry|October 17, 2025
The Development of Stereoselective Substrate and Reagent-Controlled Lithiation-Borylation ChemistryYannick Linne, Maike Birkner, Daniel Lücke, et al.
Chembiochem : a European Journal of Chemical Biology|April 3, 2014
Baceridin, a cyclic hexapeptide from an epiphytic bacillus strain, inhibits the proteasomeJutta Niggemann, Przemyslaw Bozko, Nicole Bruns, et al.
Cancers|March 12, 2020
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR InhibitionJun Xing, Vikas Bhuria, Khac Cuong Bui, et al.
Neuropharmacology|September 25, 2018
Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacyClaudia Brandt, Patricia Seja, Kathrin Töllner, et al.
Journal of Hepatology|June 14, 2015
Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activityGeorge Koutsoudakis, Inés Romero-Brey, Carola Berger, et al.
Cancer Cell|July 5, 2008
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibitionIrina Nickeleit, Steffen Zender, Florenz Sasse, et al.
Nature Communications|December 1, 2022
Moonlighting chaperone activity of the enzyme PqsE contributes to RhlR-controlled virulence of Pseudomonas aeruginosaSebastian Roman Borgert, Steffi Henke, Florian Witzgall, et al.
Immunity|November 25, 2020
Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein SynthesisLuís Almeida, Ayesha Dhillon-LaBrooy, Carla N Castro, et al.
Pageof 8